Background. Candida bloodstream infections cause significant morbidity and mortality among hospitalized patients. Although clinical and microbiological factors affecting prognosis have been identified, the impact of genetic variation in the innate immune responses mediated by cytokines on outcomes of infection remains to be studied.
and killing of invading pathogens, as well as through activation of adaptive immunity through antigen presentation and secretion of proinflammatory cytokines [3] . Adaptive fungal immunity stimulates host responses to pathogens via protective cellular T-helper 1 (Th1) cytokines, such as interferon-c (IFNc), and humoral Th2 responses that may have maladaptive antiinflammatory effects by the release of interleukin (IL)-4 and IL-10. The interplay between Th1 and Th2 responses to Candida infection is complex but critical for the response to this pathogen. Previous studies have demonstrated that vigorous Th1-type responses are essential for eradication of Candida [4, 5] . In contrast, Th2-type responses to Candida may lead to downregulation of proinflammatory cytokines, thereby terminating the protective response to infection [6] .
Genetic factors are known to have an important impact on susceptibility to infections [7] . Although much has been learned about the immune mechanisms that determine an effective host defense against Candida, very little is known about the role played by single-nucleotide polymorphisms (SNPs) of genes comprising the cytokine network for susceptibility to systemic candidiasis. This study was undertaken to investigate the role of polymorphisms in the main cytokine genes for the susceptibility to Candida infection and to assess whether there is any association with the subsequent clinical outcome.
METHODS

Study Design
This was a prospective, observational cohort study conducted at Duke University Medical Center (DUMC) and Radboud University Nijmegen Medical Center (RUNMC). Subjects were enrolled after informed consent (or waiver as approved by the institutional review boards) at DUMC (Durham, North Carolina) and RUNMC (Nijmegen, the Netherlands). The study was approved by the institutional review board at each study center, and enrollment took place between January 2003 and January 2009. The study was performed in accordance with the Declaration of Helsinki.
Subjects
Infected adults ($18 years of age) were identified by report of $1 positive blood cultures for Candida species in the clinical microbiology laboratory at the participating center. Noninfected controls recruited at DUMC must have been hospitalized with no history or evidence of candidemia/invasive candidiasis or any other invasive fungal infection. Noninfected controls at DUMC were recruited from the same hospital wards as infected patients so that comorbidities and clinical risk factors for infection would be as similar as possible between groups. Noninfected controls enrolled at RUNMC were nonhospitalized healthy controls. Subjects were excluded from the study if insufficient volume of blood or clinical data were available. Intergroup comparisons between the 2 groups of noninfected subjects and between the 2 groups of infected subjects (at DUMC and RUNMC) were performed regarding similarity in genetic distribution of the studied SNPs prior to further statistical analysis of infected versus noninfected subjects.
Procedures
Plasma, serum, and whole blood specimens were obtained in combination with routine blood draws at baseline and during a 12-week follow-up period. Blood cultures were drawn as part of routine care until clearance of fungemia was documented or death occurred. For genetic analysis, DNA was isolated from whole blood by standard procedures. For in vitro peripheral blood mononuclear cell (PBMC) stimulation assays, blood was drawn from healthy volunteers recruited at RUNMC.
Outcomes
Presence of invasive candidiasis was determined on the basis of the European Organization for Research and Treatment of Cancer definitions. All-cause mortality was determined based on hospital records and, if necessary for DUMC subjects, the Social Security Death Index. Disseminated disease was defined as the presence of Candida species at normally sterile sites outside the bloodstream (excluding the urine) and further characterized as acute or chronic. Persistent fungemia was defined as $5 days of persistently positive blood cultures for the same Candida species. All infected patients were followed for up to 12 weeks to assess for clinical outcome.
Predictor Variables
Within the DUMC infected cohort, numerous baseline clinical and microbiological variables were assessed for their relationship to study outcomes. These included age, race, sex, and immunocompromised host status (see Table 2 ).
Genotyping
Mostly SNPs in promoter and 5#-untranslated regions of the analyzed genes were selected on the basis of previously established associations with human diseases or known functional effects on protein function or gene expression. SNPs in 6 cytokine genes (IL1b, IL8, IL10, IL12B, IL18, IFNG) and 1 cytokine receptor gene (IL12RB1) were genotyped (Supplementary Table 1 ) by using a mass-spectrometry genotyping platform (Sequenom, LUMC). Quality control was performed by duplicating samples within and across plates and by incorporation of positive control samples.
In Vitro PBMC Stimulation Assays
Isolation and stimulation of PBMCs was performed as described elsewhere [8] . In brief, PBMCs obtained from individuals were incubated at 37°C for 48 hours with either culture medium or with Candida albicans conidia or hyphae (strain UC820, both 10 6 /mL). Production of IL-10 and IFN-c was measured in PBMC supernatants by enzyme-linked immunosorbent assay (R&D Systems and Sanquin).
Cytokine Assays
Cytokine concentrations of IL-6, IL-8, IFN-c, IL-10, and IL-12p40 in plasma and serum samples obtained from infected patients from day 0 to day 7 after initial positive blood culture were measured by Multiplex Fluorescent Bead Immunoassays (xMAP technology, Bio-Rad) and a Bio-plex microbead analyzer (Luminex) according to the manufacturer's protocol. Day 0 was defined as the date that the first positive blood culture was drawn.
Statistical Analysis
For the genetic analysis, statistical tests for single locus association and for deviations from Hardy-Weinberg equilibrium (HWE) for all SNPs were calculated using PLINK statistical software [9] . Statistical significance for deviations from HWE in cases and controls were determined using v 2 tests. Single locus tests of association were performed with logistic regression using both a dominant and a recessive model. Standard summary statistics (odds ratio [OR] and 95% confidence interval [CI]) were reported for these tests of association. Pairwise linkage disequilibrium (LD), D# and r 2 , were calculated using Haploview software [10] . Haplotype blocks were assigned using the D# confidence interval algorithm created by Gabriel et al [11] . Data on susceptibility to infection were analyzed for white descendents separately from blacks because allelic frequencies were expected to differ among these 2 populations and controls. Within the infected DUMC cohort, allelic frequencies were further assessed in association with 3 prespecified clinical outcomes: (1) disseminated disease, (2) persistent fungemia, and (3) all-cause mortality at 30 days. This analysis was performed in the entire cohort, and race was considered as a covariate in the analysis. Variables with P values ,.2 in the univariate analysis or thought to be clinically important were further assessed in multivariable logistic regression models. Only variables with P values ,.05 were retained in the final predictive model. ORs and 95% CIs were reported for variables that remained significant in the final multivariable model.
For the analysis of cytokine concentrations in the in vitro PBMC stimulation assays and in serum/plasma from the infected patients, Mann-Whitney U tests were performed to test for statistical differences. All tests were 2-sided.
RESULTS
Baseline Characteristics
In total, 338 infected (298 DUMC, 40 RUNMC) and 351 (300 DUMC, 51 RUNMC) noninfected adults were included ( Table 1 ). The white patient group consisted of 237 infected and 263 noninfected subjects.
Clinical characteristics of infected and noninfected subjects from DUMC were similar ( Table 2 ). The following Candida species were commonly identified in the blood of infected subjects: C. albicans (42%), C. glabrata (29%), C. parapsilosis (16%), C. tropicalis (13%), C. krusei (4%). In sum, 5% of subjects had .1 Candida species isolated. Persistent fungemia was found in 13% of individual cases. Disseminated disease was observed in 18% of infected cases, and 30-day mortality was 29%.
Susceptibility to Infection
All infected patients and noninfected controls were successfully genotyped for all variants. All variants were in HWE (data not shown). The intergroup comparison between the Dutch RUNMC and Caucasian DUMC noninfected controls and between the infected subjects recruited at DUMC and RUNMC revealed a similar genetic distribution of the genotyped SNPs, which allowed the groups to be merged into 1 group of noninfected controls and 1 group of infected subjects (data not shown). Allelic frequencies of the cytokine SNPs did not differ significantly between infected and noninfected white subjects (Table 3) . Similar results were obtained in the EuropeanAmerican group, when analyzed separately (not shown).
Similarly, no association between cytokine polymorphisms and susceptibility to bloodstream Candida infections was observed in the black cohort (Table 4) . Therefore, none of the cytokine SNPs studied were associated with susceptibility to candidemia.
Univariate Analysis of Clinical Outcomes
In the DUMC infected cohort, variables that were significantly associated with persistent fungemia on univariate analysis included immunocompromised status, receipt of TPN, and C. parapsilosis infection. Of the cytokine SNPs tested, polymorphisms in IL10 and IL12B genes were associated with persistent fungemia using univariate analysis in a recessive model (Table 5 ). In contrast, no association was observed 
In Vitro Cytokine Production by PBMCs
Stimulation of PBMCs obtained from healthy individuals bearing different IL10 rs1800896 genotypes with either C. albicans conidia or C. albicans hyphae for 48 hours revealed increased production of IL-10 upon stimulation with C. albicans conidia in PBMCs from individuals homozygous for the IL10 rs1800896 G allele, compared with PBMCs from individuals homozygous for the A allele. Individuals heterozygous for this polymorphism exhibited an intermediate production of IL-10. The production capacity of PBMCs after stimulation with C. albicans hyphae was very low and revealed no differences between genotypes ( Figure 1A ). When PBMCs were stimulated with these same stimuli and were stratified for their IL12B rs41292470 genotype, a 3-fold increased production of IFN-c was observed by PBMCs homozygous for the insertion allele, compared with PBMCs from individuals homozygous for the IL12B deletion allele upon stimulation with C. albicans hyphae but not conidia. Again, PBMCs from heterozygous individuals produced intermediate amounts of IFN-c ( Figure 1B ).
Circulating Cytokine Concentrations
Lower proinflammatory cytokine concentrations (IFN-c, IL-8, IL-6) were apparent in serum/plasma from patients with persistent fungemia, compared with patients who cleared Candida rapidly. While the differences were statistically significant for IFN-c and IL-8, the differences in circulating IL-6 concentrations were not statistically significant (Table 6 , Mann-Whitney U test).
DISCUSSION
The interest in genetic susceptibility to systemic fungal infections has increased in recent years, being stimulated by the discovery of several polymorphisms in immune genes associated with invasive fungal infections such as aspergillosis [12, 13] . However, much less is known in patients with systemic Candida infections, and no systematic study has been dedicated to this most prevalent systemic fungal infection. To our knowledge, this is the first large prospective study aimed at characterizing the role of SNPs in genes of the cytokine network along with other risk factors for susceptibility to invasive Candida infections. The first observation made in this study is that SNPs in the cytokine genes, chosen on the basis of in vitro and clinical studies suggesting a functional role in infection, do not seem to impact the overall susceptibility to systemic Candida infections. This conclusion is supported by analysis of both patients with European and African ancestry. In addition, no differences in the Candida species were identified between patients with different cytokine polymorphisms, compared with those carrying wild-type alleles. It appears therefore that exogenous factors well known to impact susceptibility to systemic fungal infections (neutropenia, total parenteral nutrition, dialysis, intensive care unit stay) may supersede the impact of cytokine polymorphisms. Alternatively, polymorphisms in other important classes of innate immunity genes such as TLR4, TLR2, or TLR1, may play a more important role in the susceptibility to acquire the infection [14, 15] .
In contrast to the conditions influencing susceptibility to infection, a different set of factors is likely to determine the progression of the disease. In sepsis patients, one of the major factors impacting the outcome of the infection is represented by development of immunoparalysis. Immunoparalysis is characterized by counterregulatory antiinflammatory responses, decreased expression of major histocompatibility complex class II (MHC-II), and lymphocyte apoptosis. A major factor influencing these processes is represented by the capacity of the host to mount a Th1/IFN-c response, known to activate antifungal properties of neutrophils and macrophages and increase cell survival and MHC-II expression [16] . In contrast, Th2-type responses represented by the antiinflammatory cytokines IL-10 and IL-4 counteract the action of IFN-c [17] . The importance of the Th1/Th2 balance for the outcome of systemic fungal infections has been demonstrated in series of elegant experimental models [18, 19] .
These data in mouse models of candidiasis are now for the first time supported by our findings demonstrating that common polymorphisms in IL12B and IL10 have a significant impact on the persistence of systemic Candida infections in humans. IL-12 is a cytokine secreted by activated phagocytes and dendritic cells that induces IFN-c production by natural-killer and T lymphocytes. IL-12 consists of 2 subunits, p35 and p40, which are encoded by IL12A and IL12B, respectively. In previous studies, the presence of this IL12B SNP in the promoter region of the gene has been shown to be accompanied by higher production of IL-12 and IFN-c [20] . In the present study we demonstrate that an insertion/deletion polymorphism in the promoter region of IL12B influences the likelihood of the patients to develop persistent infection with Candida. While the effect of the IL12B promoter polymorphism on IL-12 expression is complex and secretion of this cytokine in vivo may be influenced by several factors including IL-10, previous studies suggested that dendritic cells from individuals bearing the IL12B insertion allele produced the highest amounts of IL-12 upon stimulation [21] . This IL12B allele proved also to protect against persistent candidemia in our study, and this is in line with the beneficial effects of enhanced IL-12/Th1 responses in fungal infections.
In contrast, IL-10 counterbalances the effects of proinflammatory cytokines, including IFN-c. The IL10 SNP at -1082 (G to A) modifies IL-10 secretion and may influence outcome in several disease states [22] . The IL10 -1082 G/A SNP lies within a putative ETS-consensus binding site and is associated (A allele) with lower IL-10 production [23, 24] . Hence, the IL10 -1082 SNP may modify the response to sepsis caused by a variety of microorganisms [25] . The G allele in the promoter region of IL10 at position -1082 was also associated with a higher rate of persistence of the infection, and in other studies individuals bearing the G allele had higher IL-10 production [26] . In the present study, this same G allele is also associated with a higher probability of developing persistent fungemia, which implies that high IL-10 production is predisposing to prolonged candidemia.
The results from the in vitro PBMC stimulation assays support the associations of the IL10 and IL12B polymorphisms with persistent fungemia. The IL10 G allele and the IL12B DEL allele, which both increase the risk for persistent fungemia, were demonstrated to modulate cytokine responses by PBMCs from healthy volunteers when stimulated with C. albicans conidia or hyphae; the IL10 G allele is associated with higher production of IL-10 by PBMCs when stimulated with C. albicans conidia, whereas the IL12B DEL allele was shown to downmodulate the production of IFN-c specifically upon stimulation with C. albicans hyphae. Unfortunately, detectable concentrations of IL-10 and IL-12 could not be measured in serum samples from our study patients, but our results are further supported by our analysis of other circulating cytokines, which demonstrate very low cytokine responses (IFN-c and IL-8) in patients with persistent fungemia. The concentrations of these circulating cytokines could not be shown to be directly related to IL12B and IL10 polymorphisms in our cohort, probably owing to the relatively small number of subjects in whom cytokines could be measured.
The important role that proficient Th1 responses play in severe systemic Candida infections is indirectly supported by the earlier observation that counterbalancing Th2/IL-10 responses are deleterious in patients with invasive aspergillosis [27] . Moreover, there is an accumulating body of evidence that treatment of patients with either invasive Candida [28] or Aspergillus [29] infections with recombinant proinflammatory cytokines such as IFN-c, granulocyte macrophage colonystimulating factor (CSF), or granulocyte CSF, has beneficial effects on the outcome of systemic fungal infections.
Other genes investigated (IL1b, IL8, IL10, IL18, IFNG, IL12RB1) did not reveal significant effects on susceptibility to systemic Candida infections or severity of the disease. In line with this lack of effect at the genetic level, cytokine production in in vitro PBMC stimulation assays and circulating concentrations of IFN-c, IL-6, and IL-8 were not influenced by the presence of these polymorphisms (data not shown).
Apart from the association of IL10 and IL12B polymorphisms, this study also revealed the association of persistent fungemia with total parenteral nutrition and dialysis dependence, which is consistent with previous studies [30] . Persistent fungemia is an increasingly recognized complication of Candida infections and has been reported in 8%-15% of candidemic patients in randomized controlled clinical trials.
In conclusion, in the present study we demonstrate that polymorphisms in genes modulating the Th1/Th2 responses (IL12B and IL10) influence the likelihood of systemic Candida infection persistence in a large cohort of patients. This study provides, to our knowledge, the first genetic markers that may be used to predict a prolonged course of disease and which need to be confirmed in future studies. Furthermore, the association of low Th1 responses with unfavorable outcome of infection provide additional arguments for adjunctive immunotherapy with recombinant IFN-c in systemic Candida infections.
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